JP6543614B2 - レチノイン酸産生剤 - Google Patents
レチノイン酸産生剤 Download PDFInfo
- Publication number
- JP6543614B2 JP6543614B2 JP2016507856A JP2016507856A JP6543614B2 JP 6543614 B2 JP6543614 B2 JP 6543614B2 JP 2016507856 A JP2016507856 A JP 2016507856A JP 2016507856 A JP2016507856 A JP 2016507856A JP 6543614 B2 JP6543614 B2 JP 6543614B2
- Authority
- JP
- Japan
- Prior art keywords
- retinoic acid
- present
- lactic acid
- immune function
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
[1]乳酸菌を有効成分として含む、レチノイン酸産生剤、
[2]乳酸菌がラクトバチルス属菌である、[1]に記載のレチノイン酸産生剤、
[3]乳酸菌がラクトバチルス・デルブリュッキー・サブスピーシーズ・ブルガリカスである、[1]又は[2]に記載のレチノイン酸産生剤、
[4]乳酸菌がラクトバチルス・デルブリュッキー・サブスピーシーズ・ブルガリカス OLL1073R−1株(受託番号FERM BP−10741)である、[1]〜[3]のいずれかに記載のレチノイン酸産生剤、
[5]単位包装当たり、前記乳酸菌を1億個以上含む、[1]〜[4]のいずれかに記載のレチノイン酸産生剤、
[6][1]〜[5]のいずれかに記載のレチノイン酸産生剤を含む、免疫機能増強剤、
[7]乳酸菌を有効成分として含む免疫機能増強剤、
[8]乳酸菌がラクトバチルス属であることを特徴とする[7]に記載の免疫機能増強剤、
[9]単位包装当たり、乳酸菌が1億個以上含むことを特徴とする[7]又は[8]に記載の免疫機能増強剤、
[10]乳酸菌がLactobacillus delbrueckii subsp. bulgaricus OLL1073R−1(FERM BP−10741)である、[7]〜[9]のいずれかに記載の免疫機能増強剤。
Claims (3)
- ラクトバチルス・デルブリュッキー・サブスピーシーズ・ブルガリカス OLL1073R−1株(受託番号FERM BP−10741)である乳酸菌を有効成分として含む、レチノイン酸産生剤。
- 単位包装当たり、前記乳酸菌を1億個以上含む、請求項1に記載のレチノイン酸産生剤。
- 請求項1又は2に記載のレチノイン酸産生剤を含む、腸管免疫系に対する免疫機能増強剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014051065 | 2014-03-14 | ||
JP2014051065 | 2014-03-14 | ||
PCT/JP2015/057560 WO2015137501A1 (ja) | 2014-03-14 | 2015-03-13 | レチノイン酸産生剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2015137501A1 JPWO2015137501A1 (ja) | 2017-04-06 |
JP6543614B2 true JP6543614B2 (ja) | 2019-07-10 |
Family
ID=54071936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016507856A Active JP6543614B2 (ja) | 2014-03-14 | 2015-03-13 | レチノイン酸産生剤 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6543614B2 (ja) |
CN (1) | CN106102755B (ja) |
HK (1) | HK1226296A1 (ja) |
SG (1) | SG11201607674SA (ja) |
WO (1) | WO2015137501A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6892079B2 (ja) * | 2017-06-29 | 2021-06-18 | 京都府公立大学法人 | 制御性t細胞誘導剤、アジュバント及び食品組成物 |
CN116096389A (zh) * | 2020-10-07 | 2023-05-09 | 株式会社资生堂 | Raldh2表达增强剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102647991B (zh) * | 2009-11-25 | 2015-05-06 | 株式会社明治 | 抗病毒剂和饮食品组合物 |
JP5571941B2 (ja) * | 2009-12-14 | 2014-08-13 | 雪印メグミルク株式会社 | 制御性t細胞増加剤 |
-
2015
- 2015-03-13 CN CN201580013813.7A patent/CN106102755B/zh active Active
- 2015-03-13 JP JP2016507856A patent/JP6543614B2/ja active Active
- 2015-03-13 WO PCT/JP2015/057560 patent/WO2015137501A1/ja active Application Filing
- 2015-03-13 SG SG11201607674SA patent/SG11201607674SA/en unknown
-
2016
- 2016-12-22 HK HK16114569A patent/HK1226296A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015137501A1 (ja) | 2015-09-17 |
SG11201607674SA (en) | 2016-11-29 |
CN106102755A (zh) | 2016-11-09 |
HK1226296A1 (zh) | 2017-09-29 |
JPWO2015137501A1 (ja) | 2017-04-06 |
CN106102755B (zh) | 2020-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Franz et al. | Enterococci as probiotics and their implications in food safety | |
JP5718916B2 (ja) | 新規なラクトバチルス・プランタラム及びこれを含む組成物 | |
JP5710250B2 (ja) | 哺乳類乳汁微生物、それらを含有する組成物および乳腺炎の治療のためのそれらの使用 | |
JP5718917B2 (ja) | 新規なラクトバチルス・プランタラム及びこれを含む組成物 | |
CN102905712B (zh) | 用于治疗肠炎的益生菌组合物 | |
JP2012510291A (ja) | 新規なラクトバチルス・プランタラム及びこれを含む組成物 | |
RU2439145C2 (ru) | Штамм микроорганизма bacillus smithii tbmi12 mscl p737 и применение его в качестве пищевой или кормовой добавки, или компонента пробиотической композиции и пробиотическая композиция | |
ES2763350B2 (es) | Cepa de christensenella minuta y uso de la misma | |
CA3123125A1 (en) | Strains, composition and method of use | |
JP2008212006A (ja) | 腸管バリア機能の機能回復剤及び腸管バリア透過性の亢進阻害剤 | |
PT1835021E (pt) | Nova estirpe que confere a um hospedeiro propriedades anti-doença e composição de células bacterianas | |
TW201902499A (zh) | 用於類鐸受體2活性化之組成物 | |
Hickson | Examining the evidence for the use of probiotics in clinical practice | |
US20240156884A1 (en) | Agent for improving mitochondrial function | |
JP6543614B2 (ja) | レチノイン酸産生剤 | |
KR101518445B1 (ko) | 장관면역 조정제 | |
JP2014166972A (ja) | 腸炎抑制剤及び飲食品 | |
KR101987678B1 (ko) | 피부염 치료용 비피도박테리움 롱검 kacc 91563 및 이를 함유하는 치즈 | |
JP6894096B2 (ja) | 軟骨再生促進用組成物 | |
Al-Yami et al. | Lactobacillus species as probiotics: isolation sources and health benefits | |
KR20240037257A (ko) | 위장관 장애의 치료에서의 사용을 위한 생리학적으로 허용되는 효모 조성물 | |
EP4180051A1 (en) | Composition for preventing or treating inflammatory bowel disease | |
JPWO2015087919A1 (ja) | 抗菌ペプチド誘導剤 | |
Ezema et al. | Yeast (Saccharomyces cerevisiae) as a probiotic of choice for broiler production | |
CN113041266A (zh) | 一株改善银屑病样小鼠病理特征的干酪乳杆菌及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190108 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190308 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190604 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190617 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6543614 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |